Tramontane Therapeutics

Tramontane Therapeutics is a gene therapy company focused on developing treatments for prevalent neurodegenerative and metabolic diseases. Tramontane uses adeno-associated virus vectors to express therapeutic proteins associated with the management of various diseases, including non-alcoholic steatohepatitis (NASH), type 2 diabetes, obesity, Alzheimer's disease, Parkinson's disease, and other central nervous system disorders related to cognitive and behavioral impairment.